Cisplatin
Alkylating Agent
DB00515
Approved Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
4
Targets
0
Resistance Mutations
0
References
3D Structure
No structure available
No co-crystal structure available
Protein Targets
Mechanism of Action
Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.
Details
DrugBank ID
DB00515 ↗
Approval Date
2000-06-01
Molecular Weight
298.035 g/mol
Drug Class
Alkylating Agent
ATC Codes
L01XA01
Synonyms
CDDP, Cis-DDP
PubChem
CID: 2767 ↗
ChEMBL
CHEMBL2068237 ↗
SMILES
N[Pt](N)(Cl)Cl
ADMET Profile
Computing properties…